Successful treatment of coronary artery perforation in an abciximab-treated patient by microcoil embolization

A R Assali; A Moustapha; S Sdringola; M Rihner; R W Smalling

doi:10.1002/1522-726x(200012)51:4<487::aid-ccd25>3.0.co;2-8

Successful treatment of coronary artery perforation in an abciximab-treated patient by microcoil embolization

Catheter Cardiovasc Interv. 2000 Dec;51(4):487-9. doi: 10.1002/1522-726x(200012)51:4<487::aid-ccd25>3.0.co;2-8.

Authors

A R Assali¹, A Moustapha, S Sdringola, M Rihner, R W Smalling

Affiliation

¹ Cardiology Division, University of Texas Medical School and Hermann Hospital, Houston, Texas 77225, USA.

PMID: 11108688
DOI: 10.1002/1522-726x(200012)51:4<487::aid-ccd25>3.0.co;2-8

Abstract

We describe a case of type 2 coronary artery perforation in a 73-year-old man undergoing coronary artery rotablation and stenting with abciximab therapy. The coronary artery perforation was successfully treated by coil embolization with Trufill pushable coils made from platinum alloy and synthetic fibers to promote maximum thrombogenicity.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Abciximab
Aged
Antibodies, Monoclonal / therapeutic use
Atherectomy, Coronary / adverse effects*
Coronary Disease / therapy*
Coronary Vessels / injuries*
Embolization, Therapeutic*
Humans
Immunoglobulin Fab Fragments / therapeutic use
Male
Platelet Glycoprotein GPIIb-IIIa Complex / therapeutic use*
Rupture
Stents

Substances

Antibodies, Monoclonal
Immunoglobulin Fab Fragments
Platelet Glycoprotein GPIIb-IIIa Complex
Abciximab